Latest filing published 13 Feb 2024 for Better Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David P. Perry appears in our data through filings on Better Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 20 filings, for trades running from 30 April 2021 to 9 February 2024.
No open-market sale appears; the market trades are 13 purchases worth €6.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants.
In size, the median ticket on the buying side is €65k. Of 7 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 13 February 2024 with a share grant in Better Therapeutics, Inc. The last insider purchase was made public on 31 July 2023, 1,181 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations